| CT (LUX) ASIA EQUITIES 2U USD | RVI ASIA EX-JAPÓN | 17,267743 | 02/11/2026 | 26,89% | 81,54% | **** |
| SANTANDER ACCIONES ESPAÑOLAS, FI B | RV ESPAÑA | 43,968164 | 30/10/2026 | 5,04% | 81,54% | ** |
| JPM JAPAN STRATEGIC VALUE A (DIST) GBP | RVI JAPÓN VALOR | 219,322804 | 02/11/2026 | 21,82% | 81,53% | *** |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO I H EUR CAP | RVI JAPÓN | 37,270000 | 02/11/2026 | 19,49% | 81,45% | **** |
| ALKEN FUND - EUROPEAN OPPORTUNITIES US3H | RVI EUROPA | 165,309973 | 30/10/2026 | · | 81,44% | ***** |
| LO FUNDS - ASIA HIGH CONVICTION SYST. NAV HDG X1 (CHF) M CAP | RVI ASIA EX-JAPÓN | 19,949035 | 30/10/2026 | 8,97% | 81,44% | **** |
| GOLDMAN SACHS EMERGING MARKETS EQUITY INCOME P CAP EUR | RVI EMERGENTES | 476,830000 | 02/11/2026 | 24,72% | 81,42% | **** |
| UBAM - SNAM JAPAN EQUITY AHC USD | RVI JAPÓN | 42,064907 | 02/11/2026 | 34,48% | 81,42% | **** |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | RVI BIOTECNOLOGÍA | 1.195,230029 | 02/11/2026 | 19,47% | 81,41% | *** |
| MFS MERIDIAN EMERGING MARKETS EQUITY FUND WH1-GBP | RVI EMERGENTES | 19,406557 | 02/11/2026 | 15,12% | 81,40% | **** |
